Jen Psaki reveals she tested positive for COVID-19
White House Press Secretary Jen Psaki announced Sunday she has tested positive for COVID-19.
Last week, President Biden traveled to Europe for a meeting with Pope Francis, the G20 summit, and the COP26 climate talks. In a statement, Psaki said she remained in the United States because members of her household tested positive for COVID-19, and after testing negative herself four days in a row, she had a positive result on Sunday.
"While I have not had close contact in person with the president or senior members of the White House staff since Wednesday and tested negative four days after that last contact, I am disclosing today's positive test out of an abundance of transparency," Psaki said. She last saw Biden on Tuesday, Psaki added, and they both were wearing masks and standing more than six feet apart.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"Thanks to the vaccine, I have only experienced mild symptoms, which has enabled me to continue working from home," Psaki said. "I will plan to return to work in person at the conclusion of the 10-day quarantine following a negative rapid test, which is an additional White House requirement beyond CDC guidance, taken out of an abundance of caution."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
'Solitude has become a notable, and worrisome, trend of our times'
Instant Opinion Opinion, comment and editorials of the day
By Anya Jaremko-Greenwold, The Week US Published
-
Blake Lively accuses rom-com costar of smear job
Speed Read The actor accused Justin Baldoni, her director and costar on "It Ends With Us," of sexual harassment and a revenge campaign
By Peter Weber, The Week US Published
-
Germany arrests anti-Islam Saudi in SUV attack
Speed Read The attack on a Christmas market in Magdeburg left five people dead and more than 200 wounded
By Peter Weber, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published